These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11827873)

  • 41. The morphological basis of dementia in Parkinson's disease.
    Ball MJ
    Can J Neurol Sci; 1984 Feb; 11(1 Suppl):180-4. PubMed ID: 6713315
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neuropsychiatric profiles in dementia.
    Johnson DK; Watts AS; Chapin BA; Anderson R; Burns JM
    Alzheimer Dis Assoc Disord; 2011; 25(4):326-32. PubMed ID: 22086220
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Is encroachment of the carotid termination into the substantia innominata associated with its atrophy and cognition in Alzheimer's disease?
    Gao FQ; Pettersen JA; Bocti C; Nestor SM; Kiss A; Black SE
    Neurobiol Aging; 2013 Jul; 34(7):1807-14. PubMed ID: 23414670
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Usefulness of MRI for diagnosing dementia].
    Tokumaru AM
    Nihon Rinsho; 2011 Oct; 69 Suppl 8():494-508. PubMed ID: 22787840
    [No Abstract]   [Full Text] [Related]  

  • 45. Temporal lobe magnetic resonance imaging can differentiate Alzheimer's disease from normal ageing, depression, vascular dementia and other causes of cognitive impairment.
    O'Brien JT; Desmond P; Ames D; Schweitzer I; Chiu E; Tress B
    Psychol Med; 1997 Nov; 27(6):1267-75. PubMed ID: 9403898
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Lewy-body variant of Alzheimer's disease. Clinical and pathological findings.
    Förstl H; Burns A; Luthert P; Cairns N; Levy R
    Br J Psychiatry; 1993 Mar; 162():385-92. PubMed ID: 8453435
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Non-Alzheimer degenerative dementias.
    Dalla Barba G; Boller F
    Curr Opin Neurol; 1994 Aug; 7(4):305-9. PubMed ID: 7524959
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Differential diagnosis of dementias].
    Ishii T
    Nihon Ika Daigaku Zasshi; 1989 Feb; 56(1):79-81. PubMed ID: 2732306
    [No Abstract]   [Full Text] [Related]  

  • 49. Note on the pathology of the basal nucleus of Meynert in degenerative brain disorders.
    Tagliavini F; Pilleri G
    Schweiz Arch Neurol Neurochir Psychiatr; 1984; 135(2):277-80. PubMed ID: 6240766
    [No Abstract]   [Full Text] [Related]  

  • 50. The contribution of transcranial magnetic stimulation in the diagnosis and in the management of dementia.
    Cantone M; Di Pino G; Capone F; Piombo M; Chiarello D; Cheeran B; Pennisi G; Di Lazzaro V
    Clin Neurophysiol; 2014 Aug; 125(8):1509-32. PubMed ID: 24840904
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [White matter alterations in neurodegenerative and vascular dementia].
    Supprian T; Kessler H; Retz W; Rösler M; Grunwald I; Reith W; Falkai P
    Radiologe; 2003 Jul; 43(7):543-51. PubMed ID: 12955217
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Imaging of neurodegenerative diseases.
    Mathews VP; Candy EJ; Bryan RN
    Curr Opin Radiol; 1992 Feb; 4(1):89-94. PubMed ID: 1739605
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dementia in Parkinson's disease. Morphometric data.
    Duyckaerts C; Gaspar P; Costa C; Bonnet AM; Hauw JJ
    Adv Neurol; 1993; 60():447-55. PubMed ID: 8420169
    [No Abstract]   [Full Text] [Related]  

  • 54. [Patchy changes in white matter in cranial computerized and magnetic resonance tomography--significance for (differential) diagnosis of dementia of the Alzheimer type and vascular dementia].
    Stoppe G; Staedt J; Bruhn H
    Fortschr Neurol Psychiatr; 1995 Nov; 63(11):425-40. PubMed ID: 8575717
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of neuroimaging in the diagnosis of vascular dementia.
    Small GW
    Acta Neurol Scand Suppl; 2002; 178():10-4. PubMed ID: 12492786
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Interest of CSF beta-amyloid1-42 and t-tau protein level determinations for the diagnosis of Alzheimer's disease].
    Smach MA; Charfeddine B; Lammouchi T; Dridi H; Ben Othman L; Bennamou S; Limem K
    Ann Biol Clin (Paris); 2008; 66(5):531-5. PubMed ID: 18957342
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neuroimaging biomarkers of neurodegenerative diseases and dementia.
    Risacher SL; Saykin AJ
    Semin Neurol; 2013 Sep; 33(4):386-416. PubMed ID: 24234359
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Imaging for dementia].
    Reith W
    Radiologe; 2015 May; 55(5):376-7. PubMed ID: 25952303
    [No Abstract]   [Full Text] [Related]  

  • 59. [Dyscirculatory (vascular) encephalopathy].
    Burtsev EM
    Zh Nevrol Psikhiatr Im S S Korsakova; 1998; 98(1):45-8. PubMed ID: 9505405
    [No Abstract]   [Full Text] [Related]  

  • 60. Galanin hyperinnervates surviving neurons of the human basal nucleus of Meynert in dementias of Alzheimer's and Parkinson's disease: a hypothesis for the role of galanin in accentuating cholinergic dysfunction in dementia.
    Chan-Palay V
    J Comp Neurol; 1988 Jul; 273(4):543-57. PubMed ID: 2463283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.